000 03887naaaa2200361uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/41778
005 20220714184130.0
020 _a978-2-88919-931-0
020 _a9782889199310
024 7 _a10.3389/978-2-88919-931-0
_cdoi
041 0 _aEnglish
042 _adc
100 1 _aHiroshi Nikaido
_4auth
_91604881
700 1 _aAttilio Vittorio Vargiu
_4auth
_91604882
700 1 _aKlaas Martinus Pos
_4auth
_91604883
700 1 _aKeith Poole
_4auth
_91604884
245 1 0 _aBad Bugs in the XXIst Century: Resistance Mediated by Multi-Drug Efflux Pumps in Gram-Negative Bacteria
260 _bFrontiers Media SA
_c2016
300 _a1 electronic resource (193 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aThe discovery of antibiotics represented a key milestone in the history of medicine. However, with the rise of these life-saving drugs came the awareness that bacteria deploy defence mechanisms to resist these antibiotics, and they are good at it. Today, we appear at a crossroads between discovery of new potent drugs and omni-resistant superbugs. Moreover, the misuse of antibiotics in different industries has increased the rate of resistance development by providing permanent selective pressure and, subsequently, enrichment of multidrug resistant pathogens. As a result, antimicrobial resistance has now become an urgent threat to public health worldwide (http://www.who.int/drugresistance/documents/surveillancereport/en/). The development of multidrug resistance (MDR) in an increasing number of pathogens, including Pseudomonas, Acinetobacter, Klebsiella, Salmonella, Burkholderia, and other Gram-negative bacteria is a most severe issue. Membrane efflux pump complexes of the Resistance-Nodulation-cell Division (RND) superfamily play a key role in the development of MDR in these bacteria. RND pumps, together with other transporters, contribute to intrinsic and acquired resistance to most, if not all, of the antimicrobial compounds available in our drug arsenal. Given the enormous drug polyspecificity of MDR efflux pumps, studies on their mechanism of action are extremely challenging, and this has negatively impacted both the development of new antibiotics that are able to evade these efflux pumps as well as the design of pump inhibitors. The collection of articles in this eBook, published as a Research Topic in Frontiers in Microbiology, section of Antimicrobials, Resistance, and Chemotherapy, aims to update the reader about the latest advances on the structure and function of RND efflux transporters, their roles in the overall multidrug resistance phenotype of Gram-negative pathogens, and on strategies to inhibit their activities. A deeper understanding of the mechanisms by which RND efflux pumps, alone or synergistically with other efflux pumps, are able to limit the concentration of antimicrobial compounds inside the bacterial cell, may pave the way for new, more directed, inhibitor and antibiotic design to ultimately overcome antimicrobial resistance by Gram-negatives.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by/4.0/
_2cc
_4https://creativecommons.org/licenses/by/4.0/
546 _aEnglish
653 _aResistance-Nodulation Division transporters
653 _amulti-drug-resistant pathogens
653 _aantibiotic resistance
653 _aGram-Negative Bacteria
653 _abacterial resistance mechanisms
653 _aSuperbugs
653 _aefflux pumps
856 4 0 _awww.oapen.org
_uhttp://journal.frontiersin.org/researchtopic/2904/bad-bugs-in-the-xxist-century-resistance-mediated-by-multi-drug-efflux-pumps-in-gram-negative-bacter
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/41778
_70
_zDOAB: description of the publication
999 _c3005586
_d3005586